Expert opinion—management of chronic myeloid leukemia after resistance to second-generation tyrosine kinase inhibitors

Regardless of line of therapy, treatment goals in chronic phase chronic myeloid leukemia (CML) are: avoid progression to accelerated phase or blast crisis CML such that patients achieve a life expectancy comparable with that of the general population; avoid adverse events (AEs); and restore and main...

Descripción completa

Detalles Bibliográficos
Autores principales: Hochhaus, Andreas, Breccia, Massimo, Saglio, Giuseppe, García-Gutiérrez, Valentín, Réa, Delphine, Janssen, Jeroen, Apperley, Jane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7266739/
https://www.ncbi.nlm.nih.gov/pubmed/32366938
http://dx.doi.org/10.1038/s41375-020-0842-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7266739/
https://www.ncbi.nlm.nih.gov/pubmed/32366938
http://dx.doi.org/10.1038/s41375-020-0842-9

Ejemplares similares